Name: Cullinan Therapeutics, Inc. (CGEM) Balance Sheet
Creator: FinSpry

Cullinan Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Cullinan Therapeutics, Inc. (CGEM) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	83.01	98.43	156.15	59.77	168.20
Short-Term Investments	315.97	368.63	311.14	230.69	42.01
Cash & Short-Term Investments	398.98	467.07	467.29	290.47	210.21
Accounts Receivable	3.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	12.69	13.12	7.18	6.10	2.07
Total Current Assets	414.67	480.19	474.47	296.56	212.28
Non-Current Assets
Property, Plant & Equipment (Net)	2.35	3.53	5.30	0.08	0.13
Long-Term Investments	204.44	0.00	80.88	140.40	0.00
Other Non-Current Assets	0.37	0.46	0.46	0.15	2.30
Total Non-Current Assets	207.16	3.99	86.65	140.62	0.00
Total Assets	621.82	484.18	561.12	437.19	214.71
Current Liabilities
Accounts Payable	1.68	2.49	2.66	3.17	9.68
Short-Term Debt	2.60	0.00	0.18	0.00	0.00
Accrued Liabilities	10.30	8.43	12.00	7.60	4.64
Other Current Liabilities	26.36	0.91	1.96	0.97	0.00
Total Current Liabilities	30.65	28.14	22.50	11.75	14.32
Non-Current Liabilities
Long-Term Debt	0.85	2.15	3.59	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.07	0.07
Total Non-Current Liabilities	0.85	2.15	3.59	0.07	0.00
Total Liabilities	31.50	30.29	26.09	11.81	14.39
Stockholders' Equity
Common Stock	0.01	0.00	0.01	0.00	0.00
Retained Earnings	-368.24	-200.86	-47.70	-158.91	-93.34
Accumulated Other Comprehensive Income	-0.13	-0.13	-2.60	-0.84	0.00
Additional Paid-in Capital	958.70	654.69	585.32	584.71	0.00
Minority Interest	0.00	0.19	0.00	0.40	0.00
Shares Outstanding	58.51	42.90	45.80	44.29	0.00
Total Stockholders' Equity	590.33	453.70	535.03	425.37	200.31
Total Liabilities & Equity	621.82	484.18	561.12	437.19	0.00